synergychc.com (SNYR): Rasio utang marang kapitalisasi buku

Logo korporat perusahaan Synergy CHC (SNYR)

High scalability for Synergy CHC Corp (SNYR) is driven by the outsourcing of health product manufacturing. This leverage chart, measuring debt to book capitalization, serves as a confidence indicator, where the level of 0.00 represents the current value. The holding company is expanding R&D in biotech and e-commerce to maintain stable potential, yet it faces rising online promotion costs in its struggle for margins against market behemoths.

SNYR Synergy CHC: Utang marang nilai buku ing interval 24.10.2024 - 03.10.2026
Produk sing diprodhuksi Synergy CHC

For Synergy CHC Corp (SNYR), this indicator assesses the capital structure stability of the consumer brand holding. The metric compares total liabilities against the book value of equity. By analyzing the history of the debt-to-book capitalization ratio, an investor determines the degree of financial leverage. A decrease in the coefficient minimizes default risk while capitalizing on wellness trends, whereas an increase in the indicator signals aggressive borrowing to scale distribution.

Perusahaan pesaing

Utang-utang marang kapitalisasi buku HLN (Haleon plc)|Utang-utang marang kapitalisasi buku kenvue.com KVUE|VRNA - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik MENS (Jyong Biotech Limited)|Ligand Pharma (LGND) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Amneal Corp|PRGO (Perrigo Company plc) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku alvotech.com|Utang marang nilai buku LQDA (Liquidia)|GLPG (Galapagos N.V.) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku ANI Pharma ANIP|Afrezza (MNKD) - Utang-utang marang nilai buku|AMPH: Utang marang nilai buku|pacira.com - Utang marang modal buku|SPRY: Utang-utang marang kapitalisasi buku|Theravance Biopharma Inc - Rasio utang marang aset resik|AQST (Aquestive Pharma) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku scPharma SCPH|Rasio utang marang kapitalisasi buku Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku China SXT Pharmaceuticals, Inc. SXTC|Utang-utang marang aset resik Eupraxia Pharmaceuticals, Inc. (EPRX)|BHST: Utang marang nilai buku|Utang-utang marang nilai buku Invizyne|oramed.com (ORMP) - Rasio utang marang kapitalisasi buku|Rasio utang marang nilai buku ENTX|HYFT (MindWalk Holdings Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku ABVC BioPharma Inc. ABVC|Rasio utang marang kapitalisasi buku Cumberland Pharma (CPIX)|QNTM (Quantum BioPharma Corp) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku FGEN (FibroGen, Inc.)|Utang marang aset resik telomirpharma.com|RANI: Utang marang nilai buku|Utang-utang marang nilai buku Rallybio Corporation|LEXX (lexariabioscience.com) - Utang marang nilai buku|Pulmatrix Corporation - Rasio utang marang aset resik|PTHL (Pheton Holdings Limited) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Aptorum (APM)|Utang-utang marang kapitalisasi buku LYRA|IBO (Impact BioMedical, Inc.) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku TNFA (TNF Pharmaceuticals, Inc.)|YCBD - Utang marang nilai buku|PRFX: Utang marang nilai buku|Rasio utang marang aset resik CYTO (Altamira Therapeutics)|LIPO: Utang-utang marang kapitalisasi buku|Utang marang nilai buku OptiNose Inc|Rasio utang marang kapitalisasi buku Pieris|Utang-utang marang nilai buku Procaps Group Corp PROC|Rasio utang marang kapitalisasi buku Petros Pharmaceuticals (PTPI)|QLI (qlsyy.net) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku ACELYRIN SLRN|TFFP (TFF Pharmaceuticals Inc.) - Rasio utang-utang marang kapitalisasi buku